Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization Via Pressure-Enabled Drug Delivery With the TriNav Infusion System (PEDD-UFE)

NCT06106633 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06106633
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06106633 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pain Reduction and Ovarian Perfusion Following Uterine Fibroid Embolization Via Pressure-Enabled Drug Delivery With the TriNav Infusion System (PEDD-UFE)
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Terminated
Start date
February 9, 2023
Completion date
January 20, 2025
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

uterine bleeding, uterine fibroid